Literature DB >> 11445858

Involvement of PI3K in PKCepsilon-mediated oncogenic signal in rat colonic epithelial cells.

E Marras1, P Concari, L Cortellezzi, D Dondi, M De Eguileor, G Perletti.   

Abstract

We have recently demonstrated that overexpression of PKCepsilon is oncogenic in colonic epithelial cells. To test whether PI3K might be an upstream effector of PKCepsilon in cell transformation, we have overexpressed the p110alpha PI3K subunit in non-transformed D/WT colonic epithelial cells. Transfectants displayed the major in vitro features of transformed cells. Interestingly, no transformation occurred when p110alpha was co-transfected with a dead-kinase PKCepsilon mutant. The p85alpha subunit of PI3K, displaying a dominant-negative-like effect, was then transfected in PKCepsilon-transformed D/epsilon cells. The transformed profile of these cells was markedly reduced. To identify which by-products of PI3K might be involved in cell transformation we have transfected the D/WT cell line with cDNAs encoding the PI3 kinases hVps34 and C2beta. Overexpression of hVps34 did not cause cell transformation. Conversely, in vitro transformation was observed when C2beta was transfected into D/WT cells. These results indicate that phosphatidylinositol-3 monophosphate does not seem to be involved in cell transformation, and that phosphatidylinositol-3,4 bisphosphate and phosphatidylinositol-3,4,5 trisphosphate are more likely involved in this process. Thus, our data support the hypothesis of a linkage between PI3K and PKCepsilon, and indicate that PI3K may act as a source of second messengers responsible for oncogenic activation of PKCepsilon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445858

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.

Authors:  Brian A McCarthy; Sophia Yancopoulos; Mike Tipping; Xiao-Jie Yan; Xue Ping Wang; Fiona Bennett; Wentian Li; Martin Lesser; Santanu Paul; Erin Boyle; Carolina Moreno; Rosa Catera; Bradley T Messmer; Giovanna Cutrona; Manlio Ferrarini; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Andrew C Rawstron; Nicholas Chiorazzi
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

2.  Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.

Authors:  Angela Russo; Mustafa Nazir Okur; Maarten Bosland; John P O'Bryan
Journal:  Cancer Lett       Date:  2015-01-23       Impact factor: 8.679

3.  Intersectin 1 is required for neuroblastoma tumorigenesis.

Authors:  A Russo; J P O'Bryan
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 4.  Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways.

Authors:  Michael P Hunter; Angela Russo; John P O'Bryan
Journal:  Int J Mol Sci       Date:  2013-04-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.